Health catalyst, inc. (HCAT)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Dec'18
Assets
Current assets:
Cash and cash equivalents

60,965

18,032

52,059

20,819

28,431

Short-term investments

143,595

210,245

189,360

33,257

4,761

Accounts receivable, net

35,367

27,570

31,019

34,472

27,696

Deferred costs

493

937

978

845

649

Prepaid expenses and other assets

9,439

7,455

6,403

5,632

5,321

Total current assets

249,859

264,239

279,819

95,025

66,858

Property and equipment, net

3,943

4,295

4,228

4,180

4,676

Intangible assets, net

31,753

25,535

26,684

27,538

28,304

Operating lease right-of-use assets

3,105

3,787

4,494

5,198

6,344

Goodwill

18,419

3,694

3,694

3,694

3,694

Other assets

1,678

810

1,050

4,041

1,099

Total assets

308,757

302,360

319,969

139,676

110,975

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable

2,736

3,622

5,179

3,035

1,812

Accrued liabilities

6,830

8,944

9,544

8,107

9,203

Acquisition-related consideration payable

3,107

2,192

3,403

2,200

2,172

Deferred revenue

35,454

30,653

32,131

34,405

24,755

Operating lease liabilities

2,301

2,806

2,790

2,761

2,577

Current portion of long-term debt

-

-

0

0

1,287

Total current liabilities

50,428

48,217

53,047

50,508

41,806

Long-term debt

48,485

48,200

47,916

47,635

18,814

Acquisition-related consideration payable, net of current portion

0

1,860

-

-

-

Deferred revenue, net of current portion

1,356

1,459

7,505

7,306

7,280

Operating lease liabilities, net of current portion

1,375

1,654

2,435

3,206

4,228

Contingent consideration liability

2,666

0

1,826

2,944

3,770

Other liabilities

326

326

687

652

0

Total liabilities

104,636

101,716

113,416

112,251

75,898

Temporary Equity, Carrying Amount, Attributable to Parent

-

-

0

584,574

409,845

Stockholders’ equity:
Preferred stock, $0.001 par value per share; 25,000,000 shares authorized as of March 31, 2020 and December 31, 2019; no shares issued and outstanding as of March 31, 2020 and December 31, 2019

0

0

0

-

-

Common stock, $0.001 par value per share; 500,000,000 shares authorized as of March 31, 2020 and December 31, 2019; 37,838,276 and 36,678,854 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

38

37

36

5

5

Additional paid-in capital

832,167

811,049

802,777

0

0

Accumulated deficit

-628,123

-610,514

-596,248

-557,163

-374,772

Accumulated other comprehensive income

39

72

-12

9

-1

Total stockholders’ equity

204,121

200,644

206,553

-557,149

-374,768

Total liabilities and stockholders’ equity

308,757

302,360

319,969

139,676

110,975